Mazetol 100 Tablet contains Carbamazepine 100 mg, an anticonvulsant and mood-stabilizing agent primarily indicated for the management of epilepsy, trigeminal neuralgia, and bipolar disorder. Carbamazepine acts by reducing synaptic transmission in the central nervous system through the inhibition of voltage-gated sodium channels, thereby stabilizing hyperexcited nerve membranes, inhibiting repetitive neuronal firing, and diminishing synaptic propagation of excitatory impulses. Mazetol 100 is effective in controlling partial seizures with complex symptomatology, generalized tonic-clonic seizures, and mixed seizure patterns. Additionally, it provides symptomatic relief in trigeminal neuralgia by modulating nerve pain and is utilized as a mood stabilizer in bipolar affective disorder to prevent manic and depressive episodes. The tablet should be administered orally, with dosage individualized based on patient response and clinical condition, starting at a low dose and titrated gradually to minimize adverse effects. Common side effects may include dizziness, drowsiness, nausea, and ataxia, while serious adverse reactions such as agranulocytosis, aplastic anemia, and Stevens-Johnson syndrome require immediate medical attention. Regular monitoring of blood counts and liver function tests is recommended during prolonged therapy. Mazetol 100 should be used under strict medical supervision, considering potential drug interactions and contraindications.